These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 34557495)

  • 1. Identification and Validation of a Nine-Gene Amino Acid Metabolism-Related Risk Signature in HCC.
    Zhao Y; Zhang J; Wang S; Jiang Q; Xu K
    Front Cell Dev Biol; 2021; 9():731790. PubMed ID: 34557495
    [No Abstract]   [Full Text] [Related]  

  • 2. A Novel Amino Acid-Related Gene Signature Predicts Overall Survival in Patients With Hepatocellular Carcinoma.
    Wang S; Huang H; Hu X; Xiao M; Yang K; Bu H; Jiang Y; Huang Z
    Cancer Rep (Hoboken); 2024 Jul; 7(7):e2131. PubMed ID: 39041652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
    Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
    Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a six-gene signature predicting overall survival for hepatocellular carcinoma.
    Liu GM; Zeng HD; Zhang CY; Xu JW
    Cancer Cell Int; 2019; 19():138. PubMed ID: 31139015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel four-lncRNA signature as a prognostic indicator in cirrhotic hepatocellular carcinoma.
    Ma L; Deng C
    PeerJ; 2019; 7():e7413. PubMed ID: 31396449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Implication of a Novel Metabolism-Related Gene Signature in Hepatocellular Carcinoma.
    Yuan C; Yuan M; Chen M; Ouyang J; Tan W; Dai F; Yang D; Liu S; Zheng Y; Zhou C; Cheng Y
    Front Oncol; 2021; 11():666199. PubMed ID: 34150630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients.
    Huang S; Li D; Zhuang L; Zhang J; Wu J
    Front Med (Lausanne); 2022; 9():850343. PubMed ID: 35685422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel lipid metabolism-based risk score model in hepatocellular carcinoma patients.
    Wang W; Zhang C; Yu Q; Zheng X; Yin C; Yan X; Liu G; Song Z
    BMC Gastroenterol; 2021 Feb; 21(1):68. PubMed ID: 33579192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and Validation of Pyroptosis-Related Gene Signature to Predict Prognosis and Reveal Immune Infiltration in Hepatocellular Carcinoma.
    Fu XW; Song CQ
    Front Cell Dev Biol; 2021; 9():748039. PubMed ID: 34820376
    [No Abstract]   [Full Text] [Related]  

  • 11. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma.
    Fang Q; Chen H
    Mol Med; 2020 Jun; 26(1):60. PubMed ID: 32552682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature.
    Zhao K; Xu L; Li F; Ao J; Jiang G; Shi R; Chen F; Luo Q
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32789471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma.
    Ni W; Bian S; Zhu M; Song Q; Zhang J; Xiao M; Zheng W
    Front Oncol; 2021; 11():629327. PubMed ID: 33718205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach.
    Dessie EY; Tu SJ; Chiang HS; Tsai JJP; Chang YS; Chang JG; Ng KL
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
    Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
    World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients.
    Zhu G; Xia H; Tang Q; Bi F
    Cancer Cell Int; 2021 Mar; 21(1):166. PubMed ID: 33712026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
    Yu J; Mao W; Xu B; Chen M
    Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prognostic model for hepatocellular carcinoma patients based on signature ferroptosis-related genes.
    Wan S; Lei Y; Li M; Wu B
    Hepatol Int; 2022 Feb; 16(1):112-124. PubMed ID: 34449009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma.
    Wang M; Huang S; Chen Z; Han Z; Li K; Chen C; Wu G; Zhao Y
    BMC Cancer; 2020 Nov; 20(1):1136. PubMed ID: 33228611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a DNA Damage Response and Repair-Related Gene-Pair Signature for Prognosis Stratification Analysis in Hepatocellular Carcinoma.
    Chen Y; Huang M; Zhu J; Xu L; Cheng W; Lu X; Yan F
    Front Pharmacol; 2022; 13():857060. PubMed ID: 35496321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.